Abstract:Retinoic acid (RA) is an embryonic morphogen used in cancer differentiation-therapy. It causes a plethora of changes in gene expression culminating in cell differentiation. We now find that amongst them, expression of the Src-family-kinase, FGR, by itself causes cell differentiation analogous to RA. The historically dominant/classical paradigm for RA mechanism of action is transcriptional activation via binding to the ligand-activated nuclear receptors, RAR/RXR. In the HL-60 human myelo-monocytic leukemia model, an actively proliferating, phenotypically immature, lineage bi-potent NCI-60 cell line, RA causes election of the myeloid lineage and phenotypic maturation with G1/0 growth inhibition. It thereby converts transformed immature proliferating tumor cells to mature growth retarded cells that bear fidelity to non-transformed mature myeloid cells. The present study finds that expression of the FGR SFK(SRC-family-kinase) alone is sufficient to induce differentiation. Akin to RA, the phenotypic conversion manifests as expression of CD38, CD11b, and ROS, as well as the p27(kip1) CDKI (cyclin-dependent-kinase-inhibitor that retards cells in G1/0) characteristic of mature myeloid cells. To pursue mechanistic insight, signaling attributes known to promote RA-induced differentiation were analyzed to see what FGR affected. RA is known to cause expression of FGR which is incorporated into and activates a putative novel cytosolic macromolecular signaling machine(signalsome) that propels differentiation. RA enhances the abundance of signalsome constituents, their associations, and their phosphorylation. The signalsome contains connected nodes that appear as a spine to which the other components are connected. The apparent nodes are RAF, LYN, FGR, SLP-76 and CBL. All of these become enriched in the nucleus after RA-treatment. NUMB and VAV appear to provide further scaffolding functions enhanced by RA. RAF in the nucleus complexes with a RARE (retinoic acid-response-element) in the promoter of the blr1 gene, which encodes a serpentine G-protein-coupled-receptor. blr1 transcriptional activation by RA depends on RAF binding. BLR1 expression is necessary to propel RA-induced differentiation, although by itself is not sufficient to cause phenotypic differentiation. Analyzing this signaling process revealed that expression of FGR mimics RA-induced enhancement of the signalsome nodes, enhancing expression of RAF and its phosphorylation, and causing BLR1 expression. Interestingly, for cd38 and blr1, FGR apparently causes expression of genes targeted by RAR/RXR even without RA. FGR thus appears to cause signaling events and phenotypic shift characteristic of RA. In sum, the data indicate that FGR is the trigger for RA-induced differentiation. Given the historical perception of FGR as a pro-proliferation, transforming-viral-oncogene, this is a surprising paradigm shift.

Post-translational Modification of Retinoic Acid Receptor Alpha and Its Roles in Tumor Cell Differentiation

Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation.

Retinoic acid signaling in development and differentiation commitment and its regulatory topology

Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells.

Small Ubiquitin‐related Modifier‐1 Modification Regulates All‐trans‐retinoic Acid‐induced Differentiation Via Stabilization of Retinoic Acid Receptor Α

The AhR agonist VAF347 augments retinoic acid-induced differentiation in leukemia cells

Oridonin Upregulates All-Trans Retinoic Acid Receptor Alpha And Induces Differentiation Of Nb4 Cells Though Nf-Kb Pathway

Retinoic Acid Induces Differentiation of Mouse F9 Embryonic Carcinoma Cell by Modulating the Mir-485 Targeting of Abhd2

A decade of molecular biology of retinoic acid receptors

Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers

Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy

Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells.

Mechanisms Ofall-Trans Retinoic Acid-Induced Differentiation of Acute Promyelocytic Leukemia Cells

Molecular Interactions of Selective Agonists and Antagonists with the Retinoic Acid Receptor γ

Inhibitory effect of retinoic acid receptor agonists on in vitro chondrogenic differentiation

Molecular Mechanisms of Retinoic Acid Action

Oncogenic Potential Of Retinoic Acid Receptor-Gamma In Hepatocellular Carcinoma

Retinoic Acid Induces Proteasome-Dependent Degradation of Retinoic Acid Receptor Α (RAR Α ) and Oncogenic RAR Α Fusion Proteins

FGR Src Family Kinase Causes Signaling and Phenotypic Shift Mimicking Retinoic Acid-Induced Differentiation of Leukemic Cells

Transcriptional Factors Mediating Retinoic Acid Signals In The Control Of Energy Metabolism

Accumulation of Hypoxia-Inducible Factor-1 Alpha Protein and Its Role in the Differentiation of Myeloid Leukemic Cells Induced by All-Trans Retinoic Acid